Emma Lowe
Psychedelic Integration Therapist; UK Harm Reduction Practitioner
UK-based psychedelic integration therapist working at the intersection of psychotherapy, harm reduction, and support for individuals navigating challenging psychedelic experiences in a country where psilocybin remains illegal.
Biography
Emma Lowe is a UK-based integration therapist working with individuals who are processing psychedelic experiences — including psilocybin, MDMA, ketamine, and other substances — within a therapeutic framework. Her work operates in the distinctive legal and cultural context of the United Kingdom, where psilocybin remains a Schedule 1 controlled substance, creating a population of people having psychedelic experiences in non-clinical settings without access to formal therapeutic support before or after.
Lowe's practice focuses on integration — the therapeutic work that begins where the psychedelic experience ends. Integration therapy addresses how individuals make sense of, metabolize, and translate insights from altered state experiences into lasting psychological change. Her approach draws on psychodynamic, somatic, and harm-reduction frameworks, offering support that is non-judgmental about the substance involved and focused on the individual's psychological wellbeing.
In the UK context, where the psychedelic therapy field is developing rapidly within academic institutions (Imperial College London, King's College London) but clinical access remains extremely limited, practitioners like Lowe fill a critical gap — providing professional psychological support for people who are pursuing psychedelic experiences in retreat settings, through underground facilitators, or in self-directed contexts. She has contributed to the harm reduction infrastructure around psychedelic use in the UK through education, training, and advocacy for evidence-based approaches to drug support services.
Organizations
Why They Matter to the LearnShrooms Community
The psychedelic therapy movement has focused heavily on clinical trial settings where support is built in, but the majority of people having psychedelic experiences globally do so outside these controlled environments. Integration therapists like Lowe who work with real-world psychedelic users in jurisdictions where these substances are illegal represent an essential and often invisible harm-reduction infrastructure.
